Predict your next investment

Private Equity
greenfield.nl

See what CB Insights has to offer

Investments

23

Portfolio Exits

5

Funds

4

About Greenfield Capital Partners

Greenfield Capital Partners is an independent Dutch private equity investor with an investments focus on private companies in The Netherlands and Belgium. Greenfield stands out for its entrepreneurial and pro-active investment approach combined with involvement, determination and reliability as core values.

Greenfield Capital Partners Headquarter Location

Huizerstraatweg 111

Naarden, 1411 GM,

Netherlands

+31 (0)35 699 3900

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Greenfield Capital Partners News

BioTrackTHC Announces $5M Funding

Oct 7, 2015

      FT. LAUDERDALE, FL, Greenfield Capital Partners invested $5 million into BioTrackTHC , a company that provides cutting-edge seed-to-sale tracking software for the legal cannabis industry. Click here for more funding data on BioTrackTHC To export BioTrackTHC funding data to PDF and Excel, click here BioTrack's technology offers a robust business intelligence platform for the cannabis industry including an Enterprise System and a Traceability System. The Enterprise System provides operators with cultivation tracking; management of inventory, patients and point-of-sale; and easy accounting reporting. The Enterprise System is currently used by over 1,200 customers across 18 states and 3 countries. BioTrack's Traceability System enables government agencies to track every gram of cannabis throughout the entire production lifecycle, from cultivation, harvest and cure, quality assurance testing, transportation, destruction, and sale. The system provides real-time reporting to assist government agencies with enforcing regulations, collecting taxes and preventing the illegal sale of cannabis. During the last two years, BioTrack has established itself as one of the leaders in the cannabis software market. The company was awarded contracts with the states of New York, Washington, New Mexico and Illinois as well as with the cannabis regulatory bodies in Uruguay and Jamaica. Greenfield Capital is making investments across the entire value-chain of the legal cannabis industry with a focus on the infrastructure supporting the market. BioTrack's industry leading position is expected to provide Greenfield with valuable information that will inform its investment process and help to drive value for other portfolio companies. About Greenfield Capital Partners Greenfield Capital Partners is a Maryland based private equity fund that is a thought leader and value driver in the legal cannabis industry. Greenfield's team has decades operational, direct investment and strategy formation experience that is unrivaled in the legal cannabis industry. Greenfield will use this experience along with its cannabis industry expertise to guide strategy and accelerate growth in all of its portfolio companies. For more information please visit http://www.greenfieldcapitallp.com About BioTrackTHC BioTrackTHC is a division of Bio-Tech Medical Software, Inc., a Florida based company, with offices in Denver, Colorado, and Washington State whose team members boast over 50 combined years in the medical industry. The company's vast level of knowledge offers a significant edge in the cannabis market. View source version on businesswire.com: http://www.businesswire.com/news/home/20151005005538/en/ (c)2011-2015 by Massinvestor, Inc. For contact info, please check out our about page.

Greenfield Capital Partners Investments

23 Investments

Greenfield Capital Partners has made 23 investments. Their latest investment was in Centralpoint as part of their Secondary Market on December 12, 2011.

CBI Logo

Greenfield Capital Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

12/14/2011

Secondary Market

Centralpoint

Yes

2

2/4/2011

Growth Equity

Brunotti

Yes

Undisclosed Angel Investors, and Undisclosed Investors

1

6/10/2010

Growth Equity

Xtandit

Yes

1

4/6/2006

Growth Equity

Subscribe to see more

$99M

Subscribe to see more

10

12/31/2004

Growth Equity - III

Subscribe to see more

$99M

Subscribe to see more

10

Date

12/14/2011

2/4/2011

6/10/2010

4/6/2006

12/31/2004

Round

Secondary Market

Growth Equity

Growth Equity

Growth Equity

Growth Equity - III

Company

Centralpoint

Brunotti

Xtandit

Subscribe to see more

Subscribe to see more

Amount

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Undisclosed Angel Investors, and Undisclosed Investors

Sources

2

1

1

10

10

Greenfield Capital Partners Portfolio Exits

5 Portfolio Exits

Greenfield Capital Partners has 5 portfolio exits. Their latest portfolio exit was Centralpoint on April 13, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

4/13/2021

Acquired

$991

3

00/00/0000

Subscribe to see more

Subscribe to see more

$991

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

4/13/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Exit

Acquired

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$991

$991

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

3

10

10

10

10

Greenfield Capital Partners Acquisitions

2 Acquisitions

Greenfield Capital Partners acquired 2 companies. Their latest acquisition was Dieseko Group on October 01, 2008.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

10/1/2008

Acq - Fin

Acq - Fin

1

8/1/2002

Subscribe to see more

$99M

Subscribe to see more

10

Date

10/1/2008

8/1/2002

Investment Stage

Acq - Fin

Companies

Subscribe to see more

Valuation

Total Funding

$99M

Note

Acq - Fin

Subscribe to see more

Sources

1

10

Greenfield Capital Partners Fund History

4 Fund Histories

Greenfield Capital Partners has 4 funds, including Greenfield Capital Fund III.

Closing Date

Fund

Fund Type

Status

Amount

Sources

2/3/2011

Greenfield Capital Fund III

Buyouts & Acquisitions

$131.17M

1

12/31/2005

Greenfield Capital Fund II

Subscribe to see more

$99M

10

12/31/1999

BergHave

Subscribe to see more

$99M

10

NEThave

Subscribe to see more

$99M

10

Closing Date

2/3/2011

12/31/2005

12/31/1999

Fund

Greenfield Capital Fund III

Greenfield Capital Fund II

BergHave

NEThave

Fund Type

Buyouts & Acquisitions

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Amount

$131.17M

$99M

$99M

$99M

Sources

1

10

10

10

Greenfield Capital Partners Team

4 Team Members

Greenfield Capital Partners has 4 team members, including current Managing Director, Paul Janssens.

Name

Work History

Title

Status

Paul Janssens

Managing Director

Current

Stef van Doesburg

Managing Director

Current

Fred Mulder

Founder

Former

Sake Wijma

Senior Partner

Former

Name

Paul Janssens

Stef van Doesburg

Fred Mulder

Sake Wijma

Work History

Title

Managing Director

Managing Director

Founder

Senior Partner

Status

Current

Current

Former

Former

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.